• Collagen Type II, Antibody
  • Legionella pneumophila Antibody, IgG by IFA
  • Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • Fungitell® ß-D Glucan, Serum
  • Parathyroid Hormone (PTH), Intact
  • IgG Index, CSF
  • MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
  • Protein, Total, Random, Urine
  • BCAT1 and IKZF1 Gene Promoter Methylation Analysis for Colorectal Cancer (Colvera®)
  • Oxcarbazepine, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Additional Testing
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.